Fondaparinux Sodium Intermediates

Founded in 2023, Suzhou Everfortune manufactures and exports specialty pharmaceutical intermediates for cystic fibrosis therapies (ivacaftor, elexacaftor, and tezacaftor intermediates), antivirals (oseltamivir intermediate), and other specialty drugs including cannabidiol, lascufloxacin, pemafibrate, nedocromil sodium, fondaparinux sodium, diroximel fumarate, and vardenafil intermediates. Backed by experienced R&D personnel and established production capacity, the company accepts buyer-specified requirements and serves customers across Europe, the Middle East, Africa, Asia, the Americas, and Australasia.